Back to Search
Start Over
BRAF -V600E-mutated Rosai-Dorfman-Destombes disease and Langerhans cell histiocytosis with response to BRAF inhibitor.
- Source :
-
Blood advances [Blood Adv] 2019 Jun 25; Vol. 3 (12), pp. 1848-1853. - Publication Year :
- 2019
- Subjects :
- Adult
Child
Child, Preschool
Female
Fluorodeoxyglucose F18 metabolism
Histiocytosis, Langerhans-Cell complications
Histiocytosis, Langerhans-Cell diagnostic imaging
Histiocytosis, Langerhans-Cell genetics
Histiocytosis, Sinus complications
Histiocytosis, Sinus diagnostic imaging
Histiocytosis, Sinus genetics
Humans
Imidazoles administration & dosage
Imidazoles therapeutic use
Infant
Magnetic Resonance Imaging methods
Male
Middle Aged
Mutation
Oximes administration & dosage
Oximes therapeutic use
Positron Emission Tomography Computed Tomography methods
Protein Kinase Inhibitors administration & dosage
Protein Kinase Inhibitors therapeutic use
Proto-Oncogene Proteins B-raf blood
Proto-Oncogene Proteins B-raf drug effects
Treatment Outcome
Histiocytosis, Langerhans-Cell drug therapy
Histiocytosis, Sinus drug therapy
Proto-Oncogene Proteins B-raf metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 2473-9537
- Volume :
- 3
- Issue :
- 12
- Database :
- MEDLINE
- Journal :
- Blood advances
- Publication Type :
- Academic Journal
- Accession number :
- 31213430
- Full Text :
- https://doi.org/10.1182/bloodadvances.2019000093